← Leaderboards
Sumana Chakravarty
Sanaria, Inc.
$4,977,582
Attributed
$9,386,054
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,386,054 · 5
By mechanism
R44$6,821,463 · 3
U44$1,995,482 · 1
R43$569,109 · 1
Top collaborators
- Stephen Lev Hoffman9 shared
Most similar at Sanaria, Inc.
Same institution · by research overlap
- Stephen Lev Hoffman$79,440,588
- Peter F. Billingsley$17,765,454
- Abraham Geevarghese Eappen$150,000
Others in their field
Top investigators on “Sporozoites”
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Stefan H.i. Kappe · Seattle Children'S Hospital$25,764,709
- Peter F. Billingsley · Sanaria, Inc.$17,765,454
- B. Kim Lee Sim · Entremed, Inc.$14,187,415
- Sean C Murphy · University Of Washington$13,325,207
- John T. Harty · University Of Iowa$10,630,998
Research focus
SporozoitesMalariaVaccinesPlasmodium FalciparumMalaria VaccinesProtective EfficacyAntigensParasitesSafetyCyclic GmpLiverClinical TrialsIn VivoDesignCulicidaeAttenuatedResearch PersonnelFeedingMethodologyMalaria InfectionFalciparum MalariaCryopreservationCost EffectiveClinical Lot
Grant awards (11)
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$1,000,000
U44 · FY2025 · AI · contact PI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$995,482
U44 · FY2024 · AI · contact PI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$968,360
R44 · FY2024 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$968,151
R44 · FY2023 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine$957,878
R44 · FY2023 · AI
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$999,306
R44 · FY2022 · AI
Automating mosquito microdissection for a malaria PfSPZ vaccine$966,428
R44 · FY2022 · AI
Manufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$961,340
R44 · FY2022 · AI · contact PI
Automating mosquito microdissection for a malaria PfSPZ vaccine$1,000,000
R44 · FY2021 · AI
Sanaria PfSPZ Vaccine Functional T Cell Assay-Hepatocyte Cytotoxicity Assay$269,124
R43 · FY2011 · AI · contact PI
Sanaria PfSPZ Vaccine Functional T Cell Assay-Hepatocyte Cytotoxicity Assay$299,985
R43 · FY2010 · AI · contact PI